Rating
Buy
Price target
$340
Previous
$290
Implied upside
+10%

Stifel analyst Tore Svanberg raised the price target on Texas Instruments (NASDAQ: TXN) to $340.00 (from $290.00) while maintaining a Buy rating.

“This week, we travelled with Texas Instruments’ Mike Beckman, VP and Head of IR, for a series of investor meetings.

Our key takeaways center on (i) the broadening of the industrial recovery in 1Q26 with management’s explicit emphasis on sustainability vs. last year’s ‘false start’; (ii) the continued ascent of the Data Center business, now ~12% of revenue and tracking toward a $2bn annualized run-rate, with XPU power representing the next leg of secular opportunity, followed by 800VDC (GaN-enabled); (iii) a measured tone on pricing, with management characterizing TXN as a price follower rather than a leader; (iv) capacity and inventory positioning that should support a wide range of demand scenarios; and (v) a structural pivot toward FCF/share growth as the elevated CapEx cycle winds down.

Our report is bifurcated into two parts: (i) high-level themes from management discussions, and (ii) topic-specific commentary.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.